1. Medicine

Category Archives: Medicine

UC Davis Emergency Medicine Faculty Honored

Posted on by

(SACRAMENTO, Calif.) - Three members of the UC Davis Department of Emergency Medicine were honored recently for their achievements and leadership at this year's annual Society for Academic Emergency Medicine (SAEM) meeting in Atlanta.

Daniel Nishijima, assistant professor of emergency medicine, received the society's Young Investigator Award for his early career accomplishments in clinical research in emergency medicine. Nishijima, who came to UC Davis as a research fellow in 2008, is becoming known as an investigator with expertise in the evaluation and management of patients with blunt head trauma. One of his current projects is a cost-effectiveness analysis of using a decision rule for CT scanning in children with blunt head trauma versus routine care. Nishijima has published 18 manuscripts (including those in press), and has been the first author on 11 of those studies. He is currently an awardee of a competitive CTSC K12 career development award, and has been successful in obtaining highly competitive intramural grants as well as securing important extramural research funding.

Erik Laurin, associate professor and director of medical student education for the department, was honored with SAEM's Master Clinician Bedside Teaching Award for 2013. Laurin, who has been a UC Davis faculty member since 1999, has long been rated by residents and medical students as one of the best teaching and mentoring physicians in the Department of Emergency Medicine. Numerous physicians who trained under Laurin sent letters of praise and support for his award's nomination. One former resident, in his letter to the SAEM's awards committee, summed up many of the sentiments about Laurin: "Erik has a way of elevating his students to the highest level and bringing the very best out of them...His unwavering support and guidance over the years has made me a better doctor and a better person because of it."

James Holmes, professor of emergency medicine, was elected to the society's board of directors. Holmes is well known for both his clinical-care expertise and research accomplishments. In addition to investigating various approaches to improving trauma care of both adults and children in emergency departments, he is working with department Chair Nathan Kuppermann to oversee a five-year, NIH training grant for research education in emergency medicine, pediatric emergency medicine and associated disciplines. His research is highly collaborative, frequently using multicenter research networks, and focuses on the care of adults and children with acute traumatic injuries.

This isn't the first time members of the department's faculty team have been honored by SAEM. Last year, Edward Panacek, professor of emergency medicine, was honored by the society with the Hal Jayne Excellence in Education Award.

UC Davis Health System is improving lives and transforming health care by providing excellent patient care, conducting groundbreaking research, fostering innovative, interprofessional education, and creating dynamic, productive partnerships with the community. The academic health system includes one of the country's best medical schools, a 619-bed acute-care teaching hospital, a 1000-member physician's practice group and the new Betty Irene Moore School of Nursing. It is home to a National Cancer Institute-designated comprehensive cancer center, an international neurodevelopmental institute, a stem cell institute and a comprehensive children's hospital. Other nationally prominent centers focus on advancing telemedicine, improving vascular care, eliminating health disparities and translating research findings into new treatments for patients. Together, they make UC Davis a hub of innovation that is transforming health for all. For more information, visit healthsystem.ucdavis.edu.

Follow this link:

UC Davis Emergency Medicine Faculty Honored

Higher medicine, food prices stoke Brazil inflation

Posted on by

Consumer prices edged up 0.3 percent in Brazil last month, fueled by higher medicine, clothing and housing prices, with 12-month inflation at 6.5 percent, the state statistics agency said Friday.

The May increase, in line with market analysts' forecasts, was lower than the 0.5 percent recorded in April and the lowest since June 2012.

The Brazilian Geography and Statistics Institute (IBGE) said medicine prices increased by 0.9 percent in May, clothing by 0.8 percent and housing by 0.7 percent.

Central Bank authorities want to bring inflation down to 4.5 percent this year.

Last month, the central bank raised its key interest rate by 0.50 points to 8.0 percent to control rising inflation, the second increase within weeks.

In April, the bank's monetary policy committee pushed the rate up by 0.25 points to 7.5 percent, the first increase since July 2011.

Experts were alarmed in March when it was confirmed that 12-month inflation reached 6.59 percent, above the official upper limit of 6.5 percent.

In 2012, Brazilian consumer prices rose 5.8 percent after a 6.5 percent hike the previous year, the highest level in seven years.

Costumers shop for jewelry at a mall in Rio de Janeiro, Brazil, on January 5, 2012. Consumer prices edged up 0.3 percent in Brazil last month, fueled by higher medicine, clothing and housing prices, with 12-month inflation at 6.5 percent, the state statistics agency said.

Here is the original post:

Higher medicine, food prices stoke Brazil inflation

Penn Medicine's Peter Reese, MD, Named a Greenwall Faculty Scholar

Posted on by

Newswise PHILADELPHIAThe Greenwall Foundation has named Penn Medicines Peter Reese, MD, MSCE, a leading voice for improving organ donor rates and access to transplant, as a 2013 Greenwall Faculty Scholar in Bioethics.

The Greenwall Faculty Scholars Program supports research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical care, biomedical research, and public policy. Dr. Reese, who is an assistant professor of Medicine and Epidemiology at Penn, is one of four innovative thinkers in the nation this year to receive the prestigious honor.

Among other projects, he will conduct a randomized controlled trial of innovative methods to improve the rates of donor registration.

The Greenwall Foundation supports this career development program to enables faculty to carry out original research on policy and moral dilemmas at the intersection of ethics and the life sciences. Scholars are selected to receive 50 percent salary support for three years to develop their research program.

Dr. Reese, who takes care of kidney transplant recipients and living kidney donors, focuses on developing effective strategies to increase access to kidney and liver transplantation. His research is motivated by the widening gap between the number of patients wait-listed for transplants and the limited number of organs available. He uses tools from epidemiology, biostatistics, health services research and medical ethics to describe disparities in transplantation and methods to overcome them. Through policy development work with the United Network for Organ Sharing, he also helps to translate clinical research into effective national policy.

Dr. Reese has written specifically about barriers to live donor transplantation, the impact of functional status on kidney transplant outcomes, and the implications of organ allocation policies for the elderly. His work was among the first to examine the practice and ethical implications of accepting live kidney donors with risk factors for kidney disease.

In recognition of his contributions to transplant research, he received a Presidential Early Career Award for Scientists and Engineers in July 2012, the highest honor bestowed by the United States Government on science and engineering professionals in the early stages of their independent research careers.

## Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

Read the original here:

Penn Medicine's Peter Reese, MD, Named a Greenwall Faculty Scholar

ICare4Autism Conference at Albert Einstein College of Medicine Attracts Over 300 People

Posted on by

NEW YORK, NY--(Marketwired - Jun 7, 2013) - On June 5, 2013 the International Center for Autism Research and Education (ICare4Autism) held the conference, "Autism: Cutting Edge Research and Promising Treatment Approaches," at Albert Einstein College of Medicine in conjunction with Montefiore Medical Center.

From neurology to psychology and everything in between, the speakers presented studies on the many aspects of autism research and treatment methods. Dr. Eric Hollander, Director of the Autism and Obsessive-Compulsive Spectrum Disorders Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chairman of the ICare4Autism Advisory Council, discussed Inflammation, Temperature and Personalized Therapeutics of ASD.

Martha Herbert, M.D., Ph.D., of Harvard Medical School and the Massachusetts General Hospital, presented her research, Taking a Fresh Look at Autism: Chronic Dynamic State, not Fixed Trait. Dr. Herbert is the Director of the TRANSCEND Research Program (Treatment Research and Neuroscience Evaluation of Neurodevelopmental Disorders) with key interests in the concept of autism as a "dynamic encephalopathy (changeable) rather than a static encephalopathy (fixed for life)."

Dr. Gary Steinman, Chairman of the Department of Biochemistry at Touro College of Osteopathic Medicine, presented Diagnosis and Treatment of Autism at Birth. Dr. Steinman's studies suggest the potential for addressing autism by looking at the role of depressed IGF (insulin-like growth factor) at birth. He is collaborating internationally to develop a protocol for early identification of autism.

Non-verbal until age 4 and diagnosed with autism himself, Dr. Stephen Shore of Adelphi University presented Special Ways and Techniques (SWAT) for Achieving Meaningful Inclusion. Dr. Shore is a self-advocate who promotes early intervention and educational strategies to embrace difference and access learned knowledge through unconventional, yet creative and effective, means.

Other presenters included Dr. Carlos A. Pardo, Dr. Theoharis C. Theoharides, Dr. Aleksandra Djukic, Dr. Nathaniel Heintz, Dr. Sophie Molholm and Dr. Alisa G. Woods.

The event is now available to view on Autism Brainstorm's website, http://www.autismbrainstorm.org as well as ICare4Autism's website, http://www.icare4autism.org.

ICare4Autism is aNew York Citybased non-profit organization that works to facilitate communication and collaboration between medical andeducational specialists worldwide with the aim to alleviate autism spectrum disorder. Together we can uncover the etiology of autism, design successful intervention strategies, and innovate sustainable inclusion practices for persons with autism.

See the original post here:

ICare4Autism Conference at Albert Einstein College of Medicine Attracts Over 300 People

Research and Markets: Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Research Report …

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tsw9vr/asiapacific) has announced the addition of the "Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" report to their offering.

The radioisotope and stable isotope markets have been segmented according to the type of isotope, and applications. Both these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (Japan, China, India, South Korea, Malaysia, Indonesia, Australia, New Zealand, and Rest of Asia) to provide in-depth information on the Asia-Pacific scenario.

The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9 million in 2017 at a CAGR of 10.5%.

The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium-201(Tl-201), gallium-67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The PET radioisotopes market is dominated by fluoride-18 (F-18), followed by rubidium-82 (Rb-82).

Segments in the therapeutic market are beta emitters, brachytherapy isotopes, and alpha emitters. Quantitative information about alpha emitters has not been arrived at, as they have not been commercialized; recent clinical studies have, however, showcased immense potential of alpha isotopes in therapies. Beta emitters contribute the highest to the therapy market, dominated by iodine-131(I-131), which is poised to grow at a CAGR of 7.7% from 2012 to 2017. The Asia-Pacific market is driven by its applications for thyroid cancer, hyperthyroidism, and non-Hodgkin's lymphoma. Significant isotopes in the brachytherapy market are cesium-131(Cs-131), iodine-125 (I-125), palladium-103 (Pd-103), and iridium-192 (Ir-192).

Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are boosting the growth of the Asia-Pacific nuclear medicine market. Upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The nuclear disaster at Fukushima nuclear plants in 2011 had a major impact on radioisotope production in Japan, which is the largest consumer market in the Asia-Pacific region. The Asia-Pacific region is insulated from the global crisis in Mo-99 supply since the production is based on local nuclear plants and OPAL reactor of ANSTO. ANSTO is deemed as the future solution to compensate global Mo-99 demand.

Major players in the radiopharmaceuticals market are Nihon Medi-Physics Co., Ltd. (Japan), Covidien PLC (U.S.), Fujifilm Corporation (Japan), ANSTO (Australia), and IBA S.A (Belgium).

The Asia-Pacific stable isotopes market is dominated by deuterium (D2), oxygen-18 (O-18), carbon-13 (C-13), and nitrogen-15 (N-15). Research, pharmaceuticals, diagnostic and therapy, and industries are major applications. The Asia-Pacific stable isotopes market was estimated at $56.1 million in 2012 and is expected to cross $100.0 million by 2017 at a CAGR of 12.6%.

The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) (U.S.) and Sigma Aldrich (U.S.) in 2012.

Go here to read the rest:

Research and Markets: Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market Research Report ...

Despite Lokayukta dampener, Gouds get fish 'medicine' ready

Posted on by

Hyderabad, June 6 (IANS) The Bathini Goud family here has begun preparations for administering the fish "prasadam" (medicine) for asthma patients here June 8-9, even as the Lokayukta has directed the government not to sponsor such events.

The family members were busy Thursday getting ready the herbal paste, which is inserted into the mouth of a live murrel fish fingerling, and slipped into the mouth of the patient as part of the traditional cure for asthma.

"As the government has given us permission to distribute the prasadam at Exhibition Grounds, we are continuing our preparations," Bathini Harinath Goud told IANS Thursday.

He said they had not yet received copies of the Lokayukta order.

"We don't want to comment without going through the order," he said. "We are continuing the arrangements, as we don't want to inconvenience guests coming from outside the city and the state," Goud said.

Lokayukta Justice B. Subhashan Reddy had Wednesday asked the government not to sponsor or support the event, saying there is no scientific proof that the substance cures asthma. While observing that it is only a superstition, the ombudsman said Goud can continue practising it as there is no law restraining such practices.

Justice Reddy, however, made it clear that public funds should not be used for the event. He said Goud should make his own arrangements for the supply of fish.

Every year, the fisheries department supplies fingerlings to thousands of patients coming from different parts of the country.

The Lokayukta has also directed that the family, and not the government, should pay Rs.2.69 lakh to the Exhibition Society for using the grounds for the event, and suggested that the society obtain an undertaking from Goud that he will pay the amount in a month.

Since only two days are left for the annual event to begin, the Lokayukta allowed the government to make arrangements like supply of water, sanitation, ambulances and security this year, and asked the government not to make such arrangements from next year.

View original post here:

Despite Lokayukta dampener, Gouds get fish 'medicine' ready

New Data on Concierge Physician Salaries Released by Concierge Medicine Today

Posted on by

(PRWEB) June 06, 2013

The Concierge Medicine Research Collective, the independent health care research depository of the concierge and direct primary care industry's trade publication, Concierge Medicine Today, has just released new data summarizing concierge medicine physician salaries. The data is based on surveys, polling analysis and verbal responses received from concierge doctors across the U.S. from 2009-2012. Here are some of the highlights:

The Collective estimates concierge medicine and direct care physicians number approximately 5,000-5,5000 physicians and/or physician clinics across the U.S. This according to in-depth review and recent examination of the national marketplace as well as interviews with corporate industry leaders. The Collective also found that the states which appear to be the leanest from a concierge physician service population perspective are in areas such as: Hawaii; Idaho; Iowa; Mississippi; Maine; New Hampshire and South Dakota. Furthermore, The Collective found the number of patients who are seeking concierge medical care in the past 24-months is far greater than the actual number of primary care and family practice concierge doctors available to serve them. Concierge medical services in rural areas like Idaho, North Dakota, South Dakota, Alaska, Hawaii, Louisiana and Mississippi are in shortly supply. Often times, they have found that there are less than half-a-dozen practitioners to serve an entire state.

"Growth in any service industry, particularly healthcare depends largely on consumer spending. Concierge medicine and it's cousin, direct primary care are approaching a tipping point," says Michael Tetreault, Executive Director of The Collective and Editor of the industry's trade publications, Concierge Medicine Today and The Direct Primary Care Journal. "Doctors are now deciding between what they have to do and what they want to do."

2013 Concierge Medicine Physician Compensation Data

When compared to traditional, insurance-based physicians working in a hospital setting, Today's Hospitalist conducted their own limited survey of non-concierge hospitalist physicians and found that the salary ranges very widely with some hospitalists making between $150,000 to $227,000 in annual income.

2013 Concierge Medicine Physician Compensation Data

It's also important to note that Concierge Medicine and Cash Only practices are on the rise (albeit a slow one) but joining ACOs jumped up from 3% to 16%, this from a 2013 MedScape Survey.

Concierge Medicine Career Satisfaction

"I think the most powerful piece of this data is this one that speaks to career satisfaction," adds Tetreault. "The modern-day primary care career path is more challenging today because things like low reimbursement, high-overhead and liability insurance only bother you when you do work that matters. The good news today is that the concierge medicine and direct primary care business models provide doctors with hope, a practical billing pattern, price transparency and trust with patients. This is a career path physicians can trust and it's a proven business model that patients value."

Read more here:

New Data on Concierge Physician Salaries Released by Concierge Medicine Today


  1. Medicine